Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $21.15M | $29.93M |
| Net Income | -$19.99M | -$9.66M |
| EPS Diluted | -$0.20 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR